Associations of cholesteryl ester transfer protein TaqIB polymorphism with the composite ischemic cardiovascular disease risk and HDL-C concentrations: A meta-analysis

International Journal of Environmental Research and Public Health

Volumn 13, Issue 9, 2016, Pages

  Guo, Shu Xia ^a,b   Yao, Ming Hong ^a,b   Ding, Yu Song ^a,b   Zhang, Jing Yu ^a,b   Yan, Yi Zhong ^a,b   Liu, Jia Ming ^a,b   Zhang, Mei ^a,b   Rui, Dong Sheng ^a,b   Niu, Qiang ^a,b   He, Jia ^a,b   Guo, Heng ^a,b   Ma, Ru Lin ^a,b  

^a Medical College   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cholesteryl ester transfer protein; Composite ischemic cardiovascular disease; HDL C; Meta analysis; Polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); ESTER; ETHNICITY; HEALTH RISK; HEALTH STATUS; POLYMORPHISM; PROTEIN;

ALLELE; ARTICLE; ASIAN; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CETP GENE; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; SENSITIVITY ANALYSIS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE ISCHEMIA; MALE; META ANALYSIS; MIDDLE AGED; RISK ASSESSMENT;

CHINA;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 84989282766     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13090882     Document Type: Article

References (86)

1. Yusuf, S.; Hawken, S.; Ôunpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigos, J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004, 364, 937–952. [CrossRef]
2. Costopoulos, C.; Niespialowska-Steuden, M.; Kukreja, N.; Gorog, D.A. Novel oral anticoagulants in acute coronary syndrome. Int. J. Cardiol. 2013, 167, 2449–2455. [CrossRef] [PubMed]
3. Goldbourt, U.; Yaari, S.; Medalie, J.H. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 107–113. [CrossRef] [PubMed]
4. Gotto, A.M.; Brinton, E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update. J. Am. Coll. Cardiol. 2004, 43, 717–724. [CrossRef] [PubMed]
5. Shah, P.K.; Kaul, S.; Nilsson, J.; Cercek, B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part I. Circulation 2001, 104, 2376–2383. [CrossRef] [PubMed]
6. Foitzik, S.; Kureck, I.M.; Rüger, M.H.; Metzler, D. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. J. Lipid Res. 2009, 50, S201–S206.
7. Tall, A.R. Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. J. Clin. Lipid. 2010, 4, 389–393. [CrossRef] [PubMed]
8. Talmud, P.J.; Hawe, E.; Robertson, K.; Miller, G.J.; Miller, N.E.; Humphries, S.E. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann. Hum. Genet. 2002, 66, 111–124. [CrossRef] [PubMed]
9. Ordovas, J.M. Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): Should we be measuring them? Clin. Chem. Lab. Med. 2000, 38, 945–949. [CrossRef] [PubMed]
10. Boekholdt, S.M.; Sacks, F.M.; Jukema, J.W.; Shepherd, J.; Freeman, D.J.; Mcmahon, A.D.; Cambien, F.; Nicaud, V.; De Grooth, G.J.; Talmud, P.J. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: Individual patient meta-analysis of 13,677 subjects. Circulation 2005, 111, 278–287. [CrossRef] [PubMed]
11. Li, Y.Y.; Wu, X.Y.; Xu, J.; Qian, Y.; Zhou, C.W.; Wang, B. Apo A5 – 1131T/C, FgB –455G/A, –148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: A meta-analysis of 15,055 subjects. Mol. Biol. Rep. 2013, 40, 1997–2014. [CrossRef] [PubMed]
12. Wang, Q.; Zhou, S.B.; Wang, L.J.; Lei, M.M.; Wang, Y.; Miao, C.; Jin, Y.Z. Seven functional polymorphisms in the CETP gene and myocardial infarction risk: A meta-analysis and meta-regression. PLoS ONE 2014, 9, e88118. [CrossRef] [PubMed]
13. Cao, M.; Zhou, Z.W.; Fang, B.J.; Zhao, C.G.; Zhou, D. Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction. Medicine 2014, 93, e160. [CrossRef] [PubMed]
14. Stroup, D.F.; Berlin, J.A.; Morton, S.C.; Olkin, I.; Williamson, G.D.; Rennie, D.; Moher, D.; Becker, B.J.; Sipe, T.A.; Thacker, S.B. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. J. Am. Med. Assoc. 2000, 283, 2008–2012. [CrossRef]
15. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Int. Med. 2009, 151, 264–269. [CrossRef] [PubMed]
16. Wells, G.A.; O’Connell, D.; Peterson, J.; Welch, V.; Shea, B.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta- analyses. Available online: www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 20 Ocotber 2011).
17. Higgins, J.P.T.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327, 557–560. [CrossRef] [PubMed]
18. Berkey, C.S.; Hoaglin, D.C.; Mosteller, F.; Colditz, G.A. A random-effects regression model for meta-analysis. Stat. Med. 1995, 14, 395–411. [CrossRef] [PubMed]
19. Mantel, N.; Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22, 639–640.
20. Dersimonian, R.; Kacker, R. Random-effects model for meta-analysis of clinical trials: An update. Contem. Clin. Trials 2007, 28, 105–114. [CrossRef] [PubMed]
21. Dersimonian, R.; Laird, N. Meta-analysis in clinical trials. Controll. Clin. Trials 1986, 7, 177–188. [CrossRef]
22. Galbraith, R.F. Graphical display of estimates having differing standard errors. Technometrics 1988, 30, 271–281. [CrossRef]
23. Tanrikulu-Kucuk, S.; Ademoglu, E.; Gurdol, F.; Bilge, A.; Mutlu-Turkoglu, U.; Nisanci, Y. Cholesteryl ester transfer protein Taq1B polymorphism in an angiographically assessed Turkish population: No effects on coronary artery disease risk. Genet. Test. Mol. Biol. 2010, 14, 637–642. [CrossRef] [PubMed]
24. Kaman, D.; N, İ.; N, İ.; Akbulut, M. TaqIB and severity of coronary artery disease in the Turkish population: A pilot study. Bosn. J. Basic Med. Sci. 2015, 15, 5344–5346. [CrossRef] [PubMed]
25. Kolovou, G.; Vasiliadis, I.; Kolovou, V.; Karakosta, A.; Mavrogeni, S.; Papadopoulou, E.; Papamentzelopoulos, S.; Giannakopoulou, V.; Marvaki, A.; Degiannis, D. The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease. Lipid. Health Dis. 2011, 10, 1264–1271. [CrossRef] [PubMed]
26. Liu, R.; Liu, Y.J.; He, L. Studies on the correlation between CETP TaqIB gene polymorphism and blood lipid and coronary heart disease. J. Tianjin Med. Univ. 2015, 2, 117–120.
27. Muendlein, A.; Saely, C.H.; Marte, T.; Schmid, F.; Koch, L.; Rein, P.; Langer, P.; Aczel, S.; Drexel, H. Synergistic effects of the apolipoprotein E ε3/ε2/ε4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 – 482 C > T polymorphisms on their association with coronary artery disease. Atherosclerosis 2008, 199, 179–186. [CrossRef] [PubMed]
28. Padmaja, N.; Kumar, R.M.; Balachander, J.; Adithan, C. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clin. Chim. Acta Int. J. Clin. Chem. 2009, 402, 139–145. [CrossRef] [PubMed]
29. Qin, Q.; Zhao, B.R.; Geng, J.; Li, Y.L.; Cui, R.Z. The association of the Hpoprotein Hpase $447X and cholesteryl ester transfer protein TaqlB polymorphism with coronary heart disease. Chin. J. Cardiol. 2004, 32, 522–525.
30. Rejeb, J.; Omezzine, A.; Rebhi, L.; Naffeti, I.; Kchok, K.; Belkahla, R.; Hadjmbarek, I.B.; Rejeb, N.B.; Nabli, N.; Boujelbene, A. Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch. Cardiovsc. Dis. 2008, 101, 629–636. [CrossRef] [PubMed]
31. Shi, C.X.; Bian, C.H.; Liu, R.; Liu, Y.J.; Zhao, Y.Q. The correlation study between CETP-TaqIB gene polymorphism and coronary heart disease. Chin. J. Care. Med. 2015, 35, 337–341.
32. Wang, W.; Zhou, X.; Liu, F.; Hu, H.N.; Han, D.F. Association of the TaqIB polymorphism and D442G mutation of cholesteryl ester transfer protein gene with coronary heart disease. Chin. J. Cardiol. 2004, 32, 981–985.
33. Wu, J.H.; Lee, Y.T.; Hsu, H.C.; Hsieh, L.L. Influence of CETP gene variation on plasma lipid levels and coronary heart disease: A survey in Taiwan. Atherosclerosis 2001, 159, 451–458. [CrossRef]
34. Yan, S.K.; Zhu, Y.L.; Cheng, S.; Song, Y.H.; Yan, X.W. Relationship between coronary heart disease and TaqIB & MspI polymorphisms of cholesteryl ester transfer protein gene in Han nationality. Chin. J. Lab. Med. 2004, 27, 671–675.
35. Zhang, Y.J.; Geng, J.; Qin, Q.; Mao, Y.M.; Cui, R.Z. The effects of TaqIB polymorphism of cholesteryl ester transfer proteinon coronary heart disease. Tianjin Med. J. 2003, 31, 758–760.
36. Zhao, S.P.; Li, H.; Xiao, Z.J.; Nie, S. The effect of TaqIB polymorphism of cholesteryl ester transfer protein gene on the lipoprotein level. Chin. J. Cardiol. 2004, 32, 816–818.
37. Zheng, K.Q.; Zhang, S.Z.; He, Y.; Zhang, L.; Zhang, K.L. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease. Chin. Med. J. 2004, 117, 1288–1292. [PubMed]
38. Arca, M.; Montali, A.; Ombres, D.; Battiloro, E.; Campagna, F.; Ricci, G.; Verna, R. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin. Genet. 2001, 60, 374–380. [CrossRef] [PubMed]
39. Corella, D.; Carrasco, P.; Amiano, P.; Arriola, L.; Chirlaque, M.D.; Huerta, J.M.; Martínez, C.; Martinez-Camblor, P.; Molina, E.; Navarro, C. Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption. Atherosclerosis 2010, 211, 531–538. [CrossRef] [PubMed]
40. Eiriksdottir, G.; Bolla, M.K.; Thorsson, B.; Sigurdsson, G.; Humphries, S.E.; Gudnason, V. The –629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 2001, 159, 187–192. [CrossRef]
41. Fumeron, F.; Betoulle, D.; Luc, G.; Behague, I.; Ricard, S.; Poirier, O.; Jemaa, R.; Evans, A.; Arveiler, D.; Marques-Vidal, P. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Investig. 1995, 96, 1664–1671. [CrossRef] [PubMed]
42. Yilmaz, H.; İsbir, T.; Agachan, B.; Karaali, Z.E. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem. Funct. 2005, 23, 23–28. [CrossRef] [PubMed]
43. Bernard, K.; Alison, P.; Sarah, P.; Sarah, C.; Linda, Y.; John, D.; Colin, M.K.; Marc, D.; Mark, L.; Richard, P. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: Discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int. J. Epidemiol. 2004, 33, 1002–1013.
44. Kuivenhoven, J.A.; Jukema, J.W.; Zwinderman, A.H.; Knijff, P.D.; McPherson, R.; Bruschke, A.V.G.; Lie, K.I.; Kastelein, J.J.P. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med. 1998, 338, 86–93. [CrossRef] [PubMed]
45. Liu, S.; Schmitz, C.; Stampfer, M.J.; Sacks, F.; Hennekens, C.H.; Lindpaintner, K.; Ridker, P.M. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 2002, 161, 469–474. [CrossRef]
46. Lu, Y.; Tayebi, N.; Li, H.; Saha, N.; Yang, H.; Heng, C.K. Association of CETP Taq1B and -629C >A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean population. Lipid. Health Dis. 2013, 12, 1–13. [CrossRef] [PubMed]
47. Mehlig, K.; Strandhagen, E.; Svensson, P.A.; Rosengren, A.; Torén, K.; Thelle, D.S.; Lissner, L. CETP TaqIB genotype modifies the association between alcohol and coronary heart disease: The INTERGENE case-control study. Alcohol 2014, 48, 695–700. [CrossRef] [PubMed]
48. Meiner, V.; Friedlander, Y.; Milo, H.; Sharon, N.; Ben-Avi, L.; Shpitzen, S.; Leitersdorf, E.; Siscovick, D.S.; Schwartz, S.M. Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction. Ann. Hum. Genet. 2008, 72, 732–741. [CrossRef] [PubMed]
49. Poduri, A.; Khullar, M.; Bahl, A.; Sharma, Y.P.; Talwar, K.K.A. Combination of proatherogenic single-nucleotide polymorphisms is associated with increased risk of coronary artery disease and myocardial infarction in Asian Indians. DNA Cell Biol. 2009, 28, 451–460. [CrossRef] [PubMed]
50. El-Aziz, T.A.A.; Mohamed, R.H.; Hagrass, H.A. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism. J. Clin. Lipid. 2014, 8, 381–389. [CrossRef] [PubMed]
51. Tenkanen, H.; Koskinen, P.; Kontula, K.; Aalto-Setälä, K.; Mänttäri, M.; Manninen, V.; Runeberg, S.L.; Taskinen, M.R.; Ehnholm, C. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum. Genet. 1991, 87, 574–578. [CrossRef] [PubMed]
52. Wang, S.H.; Cui, H.B.; Wang, D.Q.; Chen, X.M.; Zhang, H.K.; Cui, C.C.; Chen, X.Y.; Liu, X.H.; Zhang, Z.; Bai, F, et al. Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Hart population. China J. Cardiol. 2008, 36, 24–29.
53. Whiting, B.M.; Anderson, J.L.; Muhlestein, J.B.; Horne, B.D.; Bair, T.L.; Pearson, R.R.; Carlquist, J.F. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am. Heart J. 2005, 150, 243–250. [CrossRef] [PubMed]
54. Zhang, G.B.; Jiang, Z.W.; Sun, B.G.; Lu, Y.S.; Wen, Q.Z.; Zhuang, W.Y.; Wang, F. Relationship of Taq IB polymorphism in the cholesteryl ester transfer protein gene to coronary artery disease. Chin. J. Arterioscler. 2005, 13, 88–90.
55. Zhang, Y.; Xi, J.L.; Yun, M.L.; Zhang, Y.X.; Zhou, D.F. Study on the relationship between CETP polymorphism and plasma lipid in patient with CHD of Han ethnic in Hannan. Mod. Prev. Med. 2011, 38, 691–693.
56. Freeman, D.J.; Samani, N.J.; Wilson, V.; McMahon, A.D.; Braund, P.S.; Cheng, S.; Caslake, M.J.; Packard, C.J.; Gaffney, D. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the west of scotland coronary prevention study. Eur. Heart J. 2003, 24, 1833–1842. [CrossRef] [PubMed]
57. Dedoussis, G.V.; Panagiotakos, D.B.; Louizou, E.; Mantoglou, I.; Chrysohoou, C.; Lamnisou, K.; Pitsavos, C.; Stefanadis, C. Cholesteryl ester-transfer protein (CETP) polymorphism and the association of acute coronary syndromes by obesity status in Greek subjects: The CARDIO2000-GENE study. Hum. Hered. 2007, 63, 155–161. [CrossRef] [PubMed]
58. Morgan, T.M.; Krumholz, H.M.; Lifton, R.P.; Spertus, J.A. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. J. Am. Med. Assoc. 2007, 297, 1551–1561. [CrossRef] [PubMed]
59. Hsieh, M.C.; Tien, K.J.; Chang, S.J.; Lo, C.S.; Hsin, S.C.; Hsiao, J.Y.; Hsu, S.C.; Liang, H.T.; Chen, H.C.; Shin, S.J. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus. Metab. Clin. Exp. 2007, 56, 745–750. [CrossRef] [PubMed]
60. Cyrus, C.; Vatte, C.; Al-Nafie, A.; Chathoth, S.; Al-Ali, R.; Al-Shehri, A.; Akhtar, M.S.; Almansori, M.; Al-Muhanna, F.; Keating, B. The impact of common polymorphisms inCETPandABCA1genes with the risk of coronary artery disease in Saudi Arabians. Hum. Genom. 2016, 10. [CrossRef] [PubMed]
61. Tayebi, N. Association of CETP and ADTRP Genes with Coronary Artery Disease in Multi-Ethnic Singaporean Population. Master’s Thesis, National University of Singapore, Singapore, 2012.
62. Jensen, M.K.; Mukamal, K.J.; Kim, O.; Rimm, E.B. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur. Heart J. 2008, 29, 104–112. [CrossRef] [PubMed]
63. Fidani, L.; Hatzitolios, A.I.; Goulas, A.; Savopoulos, C.; Basayannis, C.; Kotsis, A. Cholesteryl ester transfer protein TaqIB and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients. Neurosci. Lett. 2005, 384, 102–105. [CrossRef] [PubMed]
64. Quarta, G.; Stanzione, R.; Evangelista, A.; Zanda, B.; Sciarretta, S.; Angelantonio, E.D.; Marchitti, S.; Murro, D.D.; Volpe, M.; Rubattu, S. A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians. J. Int. Med. 2007, 262, 555–561. [CrossRef] [PubMed]
65. Jiang, Y.Q.; Wang, F.; Zhou, L.F.; Chen, C.G.; Qi, J.Y. Relationship of cholesteryl ester transfer protein TAQIB polymorphisms with cerebral infraction. J. Med. Res. 2012, 41, 89–92.
66. Bhanushali, A.A.; Das, B.R. Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians. J.Commun. Genet. 2010, 1, 55–62. [CrossRef] [PubMed]
67. Gudnason, V.; Kakko, S.; Nicaud, V.; Savolainen, M.; Kesäniemi, Y.; Tahvanainen, E.; Humphries, S. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. Eur. J. Clin. Investig. 1999, 29, 116–128. [CrossRef]
68. Goto, A.; Sasai, K.; Suzuki, S.; Fukutomi, T.; Ito, S.; Matsushita, T.; Okamoto, M.; Suzuki, T.; Itoh, M.; Okumura-Noji, K. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: A study based on coronary angiography. Atherosclerosis 2001, 159, 153–163. [CrossRef]
69. Goff, W.L.; Guerin, M.; Nicaud, V.; Dachet, C.; Luc, G.; Arveiler, D.; Ruidavets, J.B.; Evans, A.; Kee, F.; Morrison, C. A novel cholesteryl ester transfer protein promoter polymorphism (–971G/A) associated with plasma high-density lipoprotein cholesterol levels. Atherosclerosis 2002, 161, 269–279. [CrossRef]
70. Katsunori, I.; Hiroshi, M.; Tamio, T.; Nobuhiro, Y.; Shinichi, O.; Jun, S.; Kouki, T.; Yasushi, S. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects. Metab. Clin. Exp. 2003, 52, 1564–1570.
71. Weitgasser, R.; Galvan, G.; Malaimare, L.; Derflinger, I.; Hedegger, M.; Lang, J.; Iglseder, B.; Ladurner, G.; Paulweber, B. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort. Biomed. Pharmacother. 2004, 58, 619–627. [CrossRef] [PubMed]
72. Jiang, T.; Song, X.X.; Zhang, M.; Qi, W.H.; Zhang, X.W. Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetesmellitus. Chin. J. Med. Genet. 2005, 22, 298–301.
73. Huang, Z.Y.; Guo, H.W.; Xu, Z.H.; Xue, K.; Zhou, X. Association of gene polymorphism at cholesterol ester transfer protein locus with obesity and response to dietary intervention in obesity. J. Hyg. Res. 2006, 35, 447–450.
74. Zhang, Q.; Deng, B.; Li, P.L.; Yan, Y.; Wang, X.Y. Perioperative insulin resistance and TaqIB polymorphisms of cholesteryle ester transfer protein(CETP) in patients with essential hypertension. J. Clin. Anesthesiol. 2007, 23, 973–976.
75. Cui, Y.L.; Zhao, X.L.; Wu, F.; Guo, S.J.; Li, J.J. Relationship between TaqIB genetic polymorphism at cholesterol ester transfer protein locus and the efficacy ofpolicosanol. Chin. J. New Drugs 2007, 16, 240–243.
76. Meena, K.; Misra, A.; Pandey, R.M.; Luthra, K. CETP TaqIB polymorphisms and CETP activity in normolipidemic healthy northern Indians. Diabet. Metab. Syndr. Clin. Res. Rev. 2007, 1, 239–244. [CrossRef]
77. Zhang, P.H.; Li, G.M.; Wang, Y.; Zheng, K.Q. TaqIB polymorphism in CETP gene in 140 hyperlipemia patients and lipid regulating effects of statins. J. Guangdong Med. Coll. 2008, 26, 492–495.
78. Wang, Y.Z.; Yan, S.K.; Song, Y.H. Relationship of cholesterol ester transfer protein TaqIB gene polymorphism with type2 diabetes mellitus in Chinese Han nationality patients. Chin. J. Clin. Lab. Sci. 2008, 4, 297–300.
79. Qiu, H.; Zhang, Q.; Deng, B.; Jiang, B.H.; Jin, H.G. The association study of cerebrocardiac vascular diseasew ith TaqIB gene polymorphisms of cholesteryle ester transfer protein in the patients with prmiary hypertension. Chin. J. Clin. Med. 2009, 16, 341–343.
80. Tao, X.M.; Li, G.J.; Hou, S.Q.; Xiao, Z.S.; Tong, W.J.; Liu, Y.Y.; Gang, W.U.; Zhang, Y.H.; Qiu, C.C. Association of cholesteryl ester transfer protein gene TaqIB polymorphism with essential hypertension in Chinese mongolian population. Basic Clin. Med. 2010, 30, 677–682.
81. Kappelle, P.J.W.H.; Gansevoort, R.T.; Hillege, H.J.; Wolffenbuttel, B.H.R.; Dullaart, R.P.F. Common variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio. J. Clin. Lipid. 2013, 7, 56–64. [CrossRef] [PubMed]
82. Li, J.; Zhang, L.; Xie, N.Z.; Deng, B.; Lv, L.X.; Zheng, L.Q. Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease. Genet. Mol. Res. 2014, 13, 2140–2148. [CrossRef] [PubMed]
83. Galati, F.; Colonna, P.; Galati, A.; Ciardiello, C.; Bozzetti, M.P.; Massari, S. CETP TaqIB polymorphism, serum lipid levels and risk of atrial fibrillation: A case-control study. J. Atr. Fibrillation 2014, 6, 24–29.
84. Zhai, X.H.; Hu, Y.; Xu, C.Y.; Li, Y.C.; Zhang, Z.Y. Correlation research and molecular regulation mechanism of cholesteryl ester transfer protein gene rs708272 polymorphism with exercise induced serum lipid changes in obese adolescent. J. Wuhan Inst. Phys. Educ. 2015, 49, 84–89.
85. Jeenduang, N.; Porntadavity, S.; Nuinoon, M.; Horpet, D.; Thepkwan, N.; Thaworn, P.; Theanmontri, S. Studies of the CETP TaqIB and ApoE polymorphisms in Southern Thai subjects with the metabolic syndrome. Biochem. Genet. 2015, 53, 1–16. [CrossRef] [PubMed]
86. Keene, D.; Price, C.; Shunshin, M.J.; Francis, D.P. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: Meta-analysis of randomised controlled trials including 117,411 patients. Br. Med. J. 2014, 349, g4379. [CrossRef] [PubMed]